Cigna Corporation

🇺🇸New York Stock Exchange
Back to all articles
Cigna Corporation stock analysis CI overview
Somewhat Bullish +50

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina

📈 Zacks Equity Research highlights UnitedHealth, Cigna, Humana, Centene, and Molina as key players in the Health Maintenance Organization (HMO) industry.

💰 The U.S. HMO sector benefits from diversified plans that generate steady premium income and secure contract renewals with federal and state agencies.

⚠️ Regulatory changes like the One Big Beautiful Bill Act may tighten Medicaid eligibility and reduce ACA enrollment, potentially affecting membership and reimbursements.

👴 Demand for Medicare products is expected to remain strong as the U.S. population ages, supporting enrollment and premium growth.

🤖 Investments in telehealth, AI, cloud computing, and data analytics are improving efficiency and long-term revenue prospects despite near-term costs.

🔄 Industry leaders are pursuing strategic mergers and acquisitions to expand market presence and diversify operations amid favorable borrowing conditions.

📉 The Zacks Medical-HMO industry gained 17.3% in the past year compared with the S&P 500's 31.3% growth but trades at a lower forward P/E of 16.66X.

🏆 Centene (CNC) projects 2026 premium revenues between $171-$175 billion with earnings estimated at $3.47 per share, representing a 66.8% rise.

🏥 Molina Healthcare (MOH) expects 2026 premium revenue of approximately $42 billion and has earnings pegged at $5.23 per share following the ConnectiCare acquisition.

🏢 UnitedHealth Group (UNH) continues solid growth driven by UnitedHealthcare and Optum segments with 2026 earnings estimated at $18.29 per share.

💼 Cigna (CI) demonstrates strong growth through Evernorth and Cigna Healthcare segments with 2026 earnings pegged at $30.38 per share.

🏥 Humana (HUM) delivers steady growth driven by premium income and a strong membership base with 2025 revenues implying 25.3% growth from the year-ago actual.

📊 The Zacks Industry Rank for Medical-HMOs is #27, placing it in the top 11% of 246 Zacks industries with bright near-term prospects.

🛒 Health insurers are strengthening their membership base by offering diversified, cost-effective plans with enhanced benefits to support steady enrollment growth.

🤖 Digital transformation through AI-powered chatbots and mobile health applications is revolutionizing healthcare delivery and enhancing patient experience.

📉 The industry's positioning in the top 50% of Zacks-ranked industries results from a positive earnings outlook for constituent companies in aggregate.

🔍 Centene, Molina, UnitedHealth, Cigna, and Humana are presented as stocks carrying a Zacks Rank #2 (Buy) or #3 (Hold) for investors to consider.

📈 The aging baby boomer generation entering retirement is expected to drive sustained demand for Medicare products and higher premium revenues.

🤝 Strategic transactions promote business diversification, enabling companies to maintain a competitive edge within the industry.

📉 Lower financing costs following Federal Reserve interest rate cuts in 2025 are expected to encourage greater M&A activity.

🏥 Humana's CenterWell platform focuses on meeting the evolving healthcare needs of the nation's growing senior population through personalized services.

Bullish Signals
  • The U.S. health insurance industry benefits from diversified, cost-effective plans that generate steady premium income and secure contract renewals.
  • Demand for Medicare products should remain strong as the U.S. population ages, supporting enrollment and premium growth.
  • Investments in telehealth, AI, cloud computing, and data analytics are improving efficiency, patient engagement, and long-term revenue prospects.
  • The Zacks Medical-HMO industry currently carries a Zacks Industry Rank #27, placing it in the top 11% of 246 Zacks industries.
  • Centene projects premium and service revenues within $171-$175 billion for 2026, with earnings expected to rise 66.8% to $3.47 per share.
  • Molina Healthcare expects 2026 premium revenue of approximately $42 billion, with a consensus earnings estimate of $5.23 per share.
  • UnitedHealth Group's 2026 earnings are pegged at $18.29 per share, implying 11.9% growth from the year-ago figure.
  • Cigna's 2026 earnings are pegged at $30.38 per share, indicating 1.8% growth from the prior-year figure.
  • Humana's consensus estimate for 2025 revenues implies 25.3% growth from the year-ago actual, with earnings pegged at $9.01 per share for 2026.
Risk Factors
  • The Zacks Medical-HMO industry has underperformed the S&P 500 over the past year, gaining only 17.3% compared to the index's 31.3% growth.
  • Regulatory changes such as the One Big Beautiful Bill Act could tighten Medicaid eligibility and reduce ACA enrollment, affecting membership and reimbursements.
  • Cigna's earnings growth is projected at only 1.8% for 2026, indicating minimal expansion compared to peers like Humana (25.3%) or Centene (66.8%).
  • The industry trades at a forward P/E ratio of 16.66X, which is lower than the S&P 500's 22.17X and the sector's 19.33X, potentially indicating undervaluation or limited growth expectations relative to the broader market.
Full Analysis
Zacks Equity Research released an industry outlook on June 4, 2026, highlighting five major Health Maintenance Organization (HMO) stocks: UnitedHealth Group (UNH), The Cigna Group (CI), Humana (HUM), Centene (CNC), and Molina Healthcare (MOH). The analysis identifies four key trends shaping the HMO industry: diversified offerings supporting enrollment stability despite regulatory challenges like the One Big Beautiful Bill Act, an aging U.S. population driving demand for Medicare products, digital transformation through investments in telehealth and AI, and strategic expansion via mergers and acquisitions facilitated by favorable borrowing conditions following Federal Reserve interest rate cuts in 2025. The report notes that while the Zacks Medical-HMO industry has underperformed the S&P 500 over the past year with a 17.3% gain compared to the index's 31.3%, it still trades at a forward P/E ratio of 16.66X, which is lower than both the S&P 500 and the broader medical sector. The industry holds a Zacks Industry Rank of #27, placing it in the top 11% of all tracked industries. Specific company outlooks include Centene projecting premium revenues between $171-$175 billion for 2026 with earnings estimated at $3.47 per share; Molina Healthcare expecting approximately $42 billion in 2026 premium revenue and earnings pegged at $5.23 per share; UnitedHealth Group forecasting $18.29 per share in 2026 earnings; Cigna projecting $30.38 per share in 2026 earnings; and Humana with 2025 revenues implying 25.3% growth from the prior year. All five companies are noted as having either a Zacks Rank #1 (Strong Buy) or #2/#3 (Buy/Hold).